FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hester Visser

Research Profile

Disorders

Migraine Disorders

Chemicals & Drugs

Procedures

Phenomena

Recurrence

Concepts & Ideas

Devices

Placebos

Co-author Network

Publications

TOP 3
W Hester Visser; Paul Winner; Kim Strohmaier; Meghan Klipfel; Yahong Peng; Kathleen McCarroll; Roger Cady; Donald Lewis; Robert Nett
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Jan Lewis Brandes; W Hester Visser; Mildred V Farmer; Amy L Schuhl; William Malbecq; France Vrijens; Christopher R Lines; Scott A Reines
Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
Christopher R Lines; W Hester Visser
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hester Visser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: W Hester Visser; Paul Winner; Kim Strohmaier; Meghan Klipfel; Yahong Peng; Kathleen McCarroll; Roger Cady; Donald Lewis; Robert Nett
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Headache 2004;44(9):891-9.
2004: Jan Lewis Brandes; W Hester Visser; Mildred V Farmer; Amy L Schuhl; William Malbecq; France Vrijens; Christopher R Lines; Scott A Reines
Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
Headache 2004;44(6):581-6.
2004: Christopher R Lines; W Hester Visser
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
International journal of clinical practice 2004;58(3):322; author reply 322-3.
2002: Paul Winner; Donald Lewis; W Hester Visser; Kaihong Jiang; Suzanne Ahrens; Judith K Evans
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
Headache 2002;42(1):49-55.
2001: Roger Cady; G Crawford; Suzanne Ahrens; D Hairwassers; A Getson; W Hester Visser; Christopher R Lines
Long-term efficacy and tolerability of rizatriptan wafers in migraine.
MedGenMed : Medscape general medicine 2001;3(3):1.
2001: Christopher R Lines; Kathleen McCarroll; W Hester Visser
Rizatriptan: pharmacological differences from sumatriptan and clinical results.
Current medical research and opinion 2001;17 Suppl 1():s54-8.
1999: Suzanne Ahrens; M V Farmer; D L Williams; E Willoughby; K Jiang; Gilbert A Block; W Hester Visser
Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group.
Cephalalgia : an international journal of headache 1999;19(5):525-30.
1998: Peer Tfelt-Hansen; J Teall; F Rodriguez; M Giacovazzo; J Paz; William Malbecq; Gilbert A Block; Scott A Reines; W Hester Visser
Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.
Headache 1998;38(10):748-55.
1996: W Hester Visser; N M Jaspers; R H de Vriend; Michel D Ferrari
Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients.
Cephalalgia : an international journal of headache 1996;16(8):554-9.
1996: W Hester Visser; Gisela M Terwindt; Scott A Reines; K Jiang; C R Lines; Michel D Ferrari
Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.
Archives of neurology 1996;53(11):1132-7.
1996: W Hester Visser; Jacobus Burggraaf; L M Muller; Rik C Schoemaker; P A Fowler; Adam Cohen; Michel D Ferrari
Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.
Clinical pharmacology and therapeutics 1996;60(4):452-60.
1996: W Hester Visser; R H de Vriend; N H Jaspers; Michel D Ferrari
Sumatriptan-nonresponders: a survey in 366 migraine patients.
Headache 1996;36(8):471-5.
1996: W Hester Visser; R H de Vriend; M W Jaspers; Michel D Ferrari
Sumatriptan in clinical practice: a 2-year review of 453 migraine patients.
Neurology 1996;47(1):46-51.
1996: W Hester Visser; N M Jaspers; R H de Vriend; Michel D Ferrari
Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients.
Cephalalgia : an international journal of headache 1996;16(4):264-9.
1996: W Hester Visser; Kenneth Klein; R C Cox; D Jones; Michel D Ferrari
311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study.
Neurology 1996;46(2):522-6.